Moreover, proliferation assays revealed that siCBX4 resulted in a significant reduction in cell proliferation compared to the control group (Figure 5D), underscoring the potential oncogenic role of CBX4 in CRC pathobiology. Here, CBX4 is linked to colorectal carcinoma.